|Former Common name||No Data|
|H-2 Haplotype||No Data|
|Strain development||Developed by Wataru Fujii, Graduate School of Agricultural and Life Sciences, The University Tokyo, and Akira Ishikawa, Graduate School of Bioagricultural Science, Nagoya University in 2015.|
|Strain description||Mice generated by the CRISPR/Cas9, which deleted a genomic fragment corresponding to exon 4 and 5 of Fap (fibroblast activation protein). Homozygous mice are viable and fertile.|
|Colony maintenance||Heterozygote x C57BL/6JJcl.|
|Health Report||No Data|
|Symbol name||fibroblast activation protein|
|Common name||No Data|
|Symbol description||No Data|
|Research applications||No Data|
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form.
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of its use with the DEPOSITOR and must obtain a prior written consent from the DEPOSITOR.
|Depositor||Ishikawa, Akira (Nagoya University)|
|Strain Status /